SignatureFD’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
CFM
HWAM
ORI
BC
DT
PFSRSONJ
CUAMC
HCMT
SignatureFD's TVTX Position: Q2 2026 in Review
SignatureFD reduced its Travere Therapeutics (TVTX) stake by 16% in Q2 2026, selling an estimated $11.3K and leaving 1,297 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.
SignatureFD first reported a position in TVTX in Q2 2019 and has held it in 17 quarters since. 35 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- SignatureFD held 1,297 shares of Travere Therapeutics worth $73.7K as of Q2 2026.
- SignatureFD sold 256 Travere Therapeutics shares in Q2 2026, an estimated $11.3K.
- Travere Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1634 holding.
- SignatureFD first reported a position in Travere Therapeutics in Q2 2019 and has held it in 17 quarters since.
- 35 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.